KLP Kapitalforvaltning’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
SL
KLP Kapitalforvaltning's RCUS Position: Q3 2026 in Review
KLP Kapitalforvaltning held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 19,300 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.
KLP Kapitalforvaltning first reported a position in RCUS in Q4 2024 and has held it in 8 quarters since. The position peaked at $595K in Q2 2026. 218 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- KLP Kapitalforvaltning held 19,300 shares of Arcus Biosciences worth $499K as of Q3 2026.
- KLP Kapitalforvaltning left its Arcus Biosciences share count unchanged in Q3 2026.
- Arcus Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1478 holding.
- KLP Kapitalforvaltning first reported a position in Arcus Biosciences in Q4 2024 and has held it in 8 quarters since.
- KLP Kapitalforvaltning's Arcus Biosciences position peaked at $595K in Q2 2026.
- 218 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.